Skip to main content

Table 1 Articles included in the clinical overview; they have been divided into 4 thematic areas based on 4 research questions: 1. role of illness awareness; 2. role of patients’ willingness; 3. role of psychopathological factors 4. therapist’s role

From: Resistance to treatment and change in anorexia nervosa: a clinical overview

Thematic area Number of articles Authors Number of patients Diagnoses Type of study
Denial versus insight of illness 7 Couturier & Lock, [25] 86 AN Retrospective cohort
Gothelf et al., [26] 281 37 AN;163 other psychiatric disorders; 81 HC Cross sectional
Konstantakopoulos et al., [27] 75 25 AN; 15 BN; 35 HC Cross sectional
Konstantakopoulos et al., [28] 72 39 AN; 33 BN Cross sectional
Schoen et al., [29] 14 AN; BN (no subgroups) Retrospective cohort
Steinglass et al., [30] 25 AN Cross sectional
Viglione et al., [31] 38 AN Cross sectional
Motivation to change 33 Ametller et al., [32] 70 AN Prospective cohort
Ben Tovim et al., [33] 220 95 AN; 88 BN; 37 EDNOS Longitudinal cohort
Bewell et al., [34] 127 AN Prospective cohort
Burket & Hodgin, [35] 72 49 BN; 11 ANBP; 6 EDNOS; 6 ANR Retrospective cohort
Carter et al., [36] 100 AN Prospective cohort
Casasnovas et al., [37] 218 58 AN; 95 BN; 65 EDNOS Cross sectional
Cavedini et al., [38] 38 AN Prospective cohort
Clausen, [39] 78 35 AN; 30 BN; 13 EDNOS Prospective cohort
Danner et al., [40] 16 AN Cross sectional
Darcy et al., [41] 20 AN Cross sectional
Gale et al., [42] 202 62 BN; 140 AN Cross sectional
Geller et al., [43] 99 15 ANBP ; 32 ANR ; 41 ANST; 7 BN; 4 BNST Test validation
Geller et al., [44] 63 24 ANR; 12 ANBP; 21 ANST; 7 BN Prospective cohort
Geller et al., [45] 128 10 ANR; 9 ANBP; 46 BN; 61 EDNOS Longitudinal cohort
Herzog et al., [46] 246 61 AN; 95 BN; 90 EDNOS Prospective cohort
Karlsson et al., [47] 89 AN Prospective cohort
Konstantakopoulos et al., [28] 72 39 AN; 33 BN Cross sectional
Lund et al., [48] 79 AN Prospective cohort
McHugh et al., [49] 65 AN Prospective cohort
Mewes et al., [50] 100 AN Prospective cohort
Muñoz et al., [51] 385 61 AN; 47 BN; 245 EDNOS Prospective cohort
Nordbø et al., [20] 18 AN Cross sectional
Nordbø et al., [52] 18 AN Cross sectional
Nordbø et al., [53] 36 AN Cross sectional
Ricca et al., [54] 103 53 AN; 50 ANST Prospective cohort
Rieger et al., [55] 44 AN Test validation
Salbach-Andrae et al., [56] 57 AN Prospective cohort
Schebendach et al., [57] 47 AN recovered Prospective cohort
Steinglass et al., [30] 25 AN Cross sectional
Touyz et al., [58]    Debate article
Treasure et al., [59]    Debate article
Wade et al., [60] 47 AN Prospective cohort
Ward et al., [61] 35 22 ANR; 11 ANBP; 2 BN Cross sectional
Maintaining factors and treatment outcome 22 Castro et al., [62] 158 AN Prospective cohort
Clausen, [39] 78 35 AN; 30 BN; 13 EDNOS Prospective cohort
Danielsen & Rø, [63] 50 30 AN; 9 BN; 11 EDNOS Prospective cohort
Deter et al., [64] 81 AN Prospective cohort
Fairburn et al., [65]    Debate article
Fassino et al., [66] 40 AN Prospective cohort
Fassino et al., [67] 42 AN Prospective cohort
Fassino et al., [68] 57 28 AN; 29 BN Prospective cohort
Federici & Kaplan, [69] 15 AN Cross sectional
Fichter et al., [18] 103 AN Prospective cohort
Geller et al., [70]    Debate article
Goddard et al., [71] 74 63 AN; 7 BN; 4 EDNOS Prospective cohort
Helverskov et al., [72] 312 58 AN; 68 EDNOS-AN; 111 BN; 75 EDNOS-BN Prospective cohort
Hjern et al., [73] 748 AN Prospective cohort
Löwe et al., [74] 84 AN Prospective cohort
Salbach-Andrae et al., [56] 57 AN Prospective cohort
Schmidt & Treasure, [75]    Debate article
Signorini et al., [76] 58 AN Prospective cohort
Steinhausen et al., [77] 60 48 ANR; 6 ANBP; 5 Atypical AN; 1 BN Prospective cohort
Sutandar-Pinnock et al., [78] 73 AN Prospective cohort
Treasure & Russell., [10]    Debate article
Vrabel et al., [79] 74 13 AN; 37 BN; 24 EDNOS Prospective cohort
Therapeutic relationship, countertransference, management of treatment resistance 18 Carter et al., [36] 100 AN Prospective cohort
Darcy et al., [41] 20 AN Cross sectional
Federici & Kaplan, [69] 15 AN Cross sectional
Feld et al., [80] 19 8ANR; 4ANBP; 4 BN; 3 EDNOS Prospective cohort
Forget et al., [81]    Debate article
Geller et al., [82] 181 Cases: 3 ANBP; 4 ANR; 22 BN; 28 EDNOS RCT
Controls:3 ANBP; 4 ANR; 21 BN; 28 EDNOS
Gulliksen et al., [53] 38 AN Cross sectional
Karlsson et al., [47] 89 AN Prospective cohort
Masson & Sheeshka, [83]    Qualitative interview
Moyers & Rollnick, [84]    Debate article
Satir et al., [85] 120 (HP)   Cross sectional
Skårderud et al., [24]    Debate article
Strober et al., [86]    Debate article
Tierney & Fox, [87] 53 (HP)   Cross sectional
Tozzi et al., [88] 70 AN Cross sectional
Treasure et al., [59]    Debate article
Vitousek et al., [89]    Debate article
Warren et al., [90] 43 (HP)   Cross sectional
  1. AN Anorexia Nervosa, BN Bulimia Nervosa, ANR Anorexia Nervosa Restricting subtype, ANBP Anorexia Nervosa Binge-Purging subtype, EDNOS Eating Disorder Not Otherwise Specified, ANST Subthreshold Anorexia Nervosa, BNST Subthreshold Bulimia Nervosa, EDNOS-AN anorexia-like eating disorder not otherwise specified-anorexia nervosa, EDNOS-BN anorexia-like eating disorder not otherwise specified-bulimia nervosa, HC Healthy Controls, HP healthcare practitioners, RCT randomized controlled trial.